E Bork
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Occupational and environmental lung diseases
- Oral health in cancer treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 9
- Lung Cancer Research Studies 6
- Cancer Diagnosis and Treatment 2
-
- Cancer therapeutics and mechanisms 4
- Biochemical and Molecular Research 3
- Co-authors
- M Hansen (6 shared papers)P Dombernowsky (5 shared papers)Hansen Hh (2 shared papers)Heine H. Hansen (2 shared papers)Jens Benn Sørensen (2 shared papers)Lars Damstrup (2 shared papers)Torben Skovsgaard (2 shared papers)Jens J. Holst (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (2 papers)Clinical Endocrinology (1 paper)Lung Cancer (1 paper)Recent results in cancer research (1 paper)
- Partner nations
- DenmarkNorwayNetherlands
In The Last Decade
E Bork
18 papers receiving 454 citations
Peers
Comparison fields: 5 of 68
- Oncology 255
- Pulmonary and Respiratory Medicine 229
- Otorhinolaryngology 29
- Epidemiology 99
- Neurology 32
Countries citing papers authored by E Bork
This map shows the geographic impact of E Bork's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bork with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bork more than expected).
Fields of papers citing papers by E Bork
This network shows the impact of papers produced by E Bork. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bork. The network helps show where E Bork may publish in the future.
Co-authors
The 25 scholars most cited alongside E Bork, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 72 | |
| 2 | Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma. | 1985 | 72 |
| 3 | 1986 | 68 | |
| 4 | 1991 | 44 | |
| 5 | 1988 | 39 | |
| 6 | 1987 | 38 | |
| 7 | 1989 | 33 | |
| 8 | Phase II study of teniposide in small cell carcinoma of the lung. | 1984 | 24 |
| 9 | 1989 | 23 | |
| 10 | 1988 | 21 | |
| 11 | 1987 | 15 | |
| 12 | 1985 | 11 | |
| 13 | 1993 | 9 | |
| 14 | 1989 | 9 | |
| 15 | 1997 | 5 | |
| 16 | 2006 | 3 | |
| 17 | Severe hyponatremia following simultaneous administration of aminoglutethimide and diuretics. | 1986 | 1 |
| 18 | [Possible incompatibility of deep radiotherapy and high-dose adriamycin or cyclophosphamide therapy in advanced genital tumors of the female]. | 1976 | 1 |
About E Bork
E Bork is a scholar working on Oncology, Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 488 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (4 papers), Oral health in cancer treatment (3 papers), Biochemical and Molecular Research (3 papers), Cancer Diagnosis and Treatment (2 papers), Neuroblastoma Research and Treatments (2 papers) and Electrolyte and hormonal disorders (2 papers). The work is most often cited by research in Oncology (255 citations), Pulmonary and Respiratory Medicine (229 citations), Otorhinolaryngology (29 citations), Epidemiology (99 citations) and Neurology (32 citations). E Bork has collaborated with scholars based in Denmark, Norway and Netherlands. Frequent co-authors include M Hansen, P Dombernowsky, Hansen Hh, Heine H. Hansen, Jens Benn Sørensen, Lars Damstrup, Torben Skovsgaard, Jens J. Holst, H.H. Hansen and Anders G. Pedersen. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Endocrinology, Lung Cancer and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.